Consistent with siRNA-mediated depletion of TFF3, AMPC inhibition of TFF3 in CMS4 CRC cells resulted in reduction of oncogenic behaviours: cell proliferation, cell survival, foci formation, 3D Matrigel growth, and reduced CSC-like behaviour. The gene discussed is TFF3; the disease is colorectal carcinoma.